Anti-CD40 antibody KPL-404 inhibits T cell-mediated activation of B cells from healthy donors and autoimmune patients | Arthritis Research & Therapy | Full Text
Anti-CD40 agonist antibodies may be the way to go for bladder cancer
Novel combination immunotherapy for pancreatic cancer: potent anti‐tumor effects with CD40 agonist and interleukin‐15 treatment - Van Audenaerde - 2020 - Clinical & Translational Immunology - Wiley Online Library
Rationale and clinical development of CD40 agonistic antibodies for cancer immunotherapy
CD40 Bioassay
Assessment of the anti-CD40 antibody iscalimab in patients with primary Sjögren's syndrome: a multicentre, randomised, double-blind, placebo- controlled, proof-of-concept study - The Lancet Rheumatology
Next-IO™ Anti-CD40 Therapeutic Monoclonal Antibody Program - Creative Biolabs
Frontiers | Next Generation CD40 Agonistic Antibodies for Cancer Immunotherapy
![PDF] Agonistic CD40 Antibodies and Cancer Therapy | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/7cb235318895039cd45eb055391de568e99105c1/2-Table1-1.png "PDF] Agonistic CD40 Antibodies and Cancer Therapy | Semantic Scholar")
PDF] Agonistic CD40 Antibodies and Cancer Therapy | Semantic Scholar
Side effects of CD40 agonistic antibodies versus fusion molecules. | Download Scientific Diagram
model of the potential effects of agonist anti-CD40 on the T-cell... | Download Scientific Diagram
Cells | Free Full-Text | Targeting the CD40-CD154 Signaling Pathway for Treatment of Autoimmune Arthritis
InVivoMAb anti-mouse CD40 | Bio X Cell
CDX-1140, A Novel Agonist CD40 Antibody with Potent Anti-lymphoma Activity
Line-selective macrophage activation with an anti-CD40 antibody drives a hemophagocytic syndrome in mice - ScienceDirect
Anti-CD40 agonistic antibody eradicates tumor and induces transient... | Download Scientific Diagram
CD40 stimulation as a molecular adjuvant for cancer vaccines and other immunotherapies | Cellular & Molecular Immunology
Cancers | Free Full-Text | Agonistic CD40 Antibodies in Cancer Treatment
Anti-CD40 clinical trials* against pancreatic cancer | Download Table
The Parker Institute for Cancer Immunotherapy and the Cancer Research Institute Announce First Patients Treated in Pancreatic Cancer Clinical Trial Combining Immunotherapy and Chemotherapy - Parker Institute for Cancer Immunotherapy
Molecular basis and therapeutic implications of CD40/CD40L immune checkpoint - ScienceDirect
CD40-agonist: A new avenue for immunotherapy combinations in cholangiocarcinoma - Journal of Hepatology
Frontiers | Next Generation CD40 Agonistic Antibodies for Cancer Immunotherapy
Dendritic cell targeting with Fc-enhanced CD40 antibody agonists induces durable antitumor immunity in humanized mouse models of bladder cancer | Science Translational Medicine
CD40
List of clinically used agonistic CD40 antibodies | Download Scientific Diagram
List of clinically used agonistic CD40 antibodies | Download Scientific Diagram
Anti-CD40 antibody KPL-404 inhibits T cell-mediated activation of B cells from healthy donors and autoimmune patients | Arthritis Research & Therapy | Full Text
